In patients with COPD and atrial fibrillation or flutter, vitamin K antagonists carry a lower 1‑year risk for hospitalization ...
Do vitamin K antagonists affect COPD outcomes? New cohort data explore exacerbation and mortality risk compared with DOACs.
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — A new study found that adding pulmonary vein isolation to cavo-tricuspid isthmus ablation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results